Iradimed Co Stock Price on December 19, 2024
| IRMD Stock | USD 54.67 0.35 0.64% |
Below is the normalized historical share price chart for Iradimed Co extending back to July 16, 2014. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Iradimed stands at 54.67, as last reported on the 28th of December, with the highest price reaching 55.23 and the lowest price hitting 53.26 during the day.
If you're considering investing in Iradimed Stock, it is important to understand the factors that can impact its price. At this point, Iradimed is very steady. Iradimed holds Efficiency (Sharpe) Ratio of 0.0764, which attests that the entity had a 0.0764% return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Iradimed, which you can use to evaluate the volatility of the firm. Please check out Iradimed's Risk Adjusted Performance of 0.0761, downside deviation of 1.89, and Market Risk Adjusted Performance of 0.2434 to validate if the risk estimate we provide is consistent with the expected return of 0.16%.
At present, Iradimed's Capital Stock is projected to increase significantly based on the last few years of reporting. The current year's Stock Based Compensation To Revenue is expected to grow to 0.04, whereas Common Stock Total Equity is forecasted to decline to 1,175. . At present, Iradimed's Price Book Value Ratio is projected to decrease significantly based on the last few years of reporting. The current year's Price Earnings To Growth Ratio is expected to grow to 1.10, whereas Price Earnings Ratio is forecasted to decline to 33.06. Iradimed Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 16th of July 2014 | 200 Day MA 46.756 | 50 Day MA 53.0537 | Beta 0.799 |
Iradimed |
Sharpe Ratio = 0.0764
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | IRMD | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.07 actual daily | 18 82% of assets are more volatile |
Expected Return
| 0.16 actual daily | 3 97% of assets have higher returns |
Risk-Adjusted Return
| 0.08 actual daily | 6 94% of assets perform better |
Based on monthly moving average Iradimed is performing at about 6% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Iradimed by adding it to a well-diversified portfolio.
Price Book 8.3576 | Enterprise Value Ebitda 29.1541 | Price Sales 9.779 | Shares Float 7.1 M | Dividend Share 0.45 |
Iradimed Main Headline on 19th of December 2024
IRADIMED CORPORATION to Present at the 43rd Annual J.P. Morg... by gurufocus.com
Search for Stocks, ETFs, Indices, Insiders, Investing Gurus and Futures on Gurufocus.com.
Iradimed Valuation on December 19, 2024
It is possible to determine the worth of Iradimed on a given historical date. On December 19, 2024 Iradimed was worth 52.57 at the beginning of the trading date compared to the closed value of 53.35. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Iradimed stock. Still, in general, we apply an absolute valuation method to find Iradimed's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Iradimed where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Iradimed's related companies.
| Open | High | Low | Close | Volume | |
| 52.95 | 54.93 | 51.87 | 52.33 | 58,280 | |
12/19/2024 | 52.57 | 53.68 | 51.58 | 53.35 | 56,725 |
| 53.26 | 55.15 | 52.90 | 54.65 | 90,292 |
| Backtest Iradimed | | | Iradimed History | | | Iradimed Valuation | Previous | Next |
Iradimed Trading Date Momentum on December 19, 2024
| On December 20 2024 Iradimed Co was traded for 54.65 at the closing time. The top price for the day was 55.15 and the lowest listed price was 52.90 . The trading volume for the day was 90.3 K. The trading history from December 20, 2024 was a factor to the next trading day price growth. The trading delta at closing time against the next closing price was 2.44% . The trading delta at closing time against the current closing price is 2.94% . |
Iradimed Fundamentals Correlations and Trends
By evaluating Iradimed's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Iradimed's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Iradimed financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Iradimed Stock history
Iradimed investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Iradimed is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Iradimed will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Iradimed stock prices may prove useful in developing a viable investing in Iradimed
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 12.7 M | 13 M | |
| Net Income Applicable To Common Shares | 14.8 M | 15.5 M |
Iradimed Quarterly Net Working Capital |
|
Iradimed Stock Technical Analysis
Iradimed technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Iradimed Period Price Range
Low | December 28, 2024
| High |
0.00 | 0.00 |
Iradimed Co cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Iradimed December 28, 2024 Market Strength
Market strength indicators help investors to evaluate how Iradimed stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Iradimed shares will generate the highest return on investment. By undertsting and applying Iradimed stock market strength indicators, traders can identify Iradimed Co entry and exit signals to maximize returns
Iradimed Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Iradimed's price direction in advance. Along with the technical and fundamental analysis of Iradimed Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Iradimed to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0761 | |||
| Jensen Alpha | 0.1529 | |||
| Total Risk Alpha | 0.1123 | |||
| Sortino Ratio | 0.0778 | |||
| Treynor Ratio | 0.2334 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Iradimed Stock analysis
When running Iradimed's price analysis, check to measure Iradimed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Iradimed is operating at the current time. Most of Iradimed's value examination focuses on studying past and present price action to predict the probability of Iradimed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Iradimed's price. Additionally, you may evaluate how the addition of Iradimed to your portfolios can decrease your overall portfolio volatility.
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |